Electronic prescribing of controlled substances (EPCS) can help deliver a number of significant benefits to providers and patients, but to enable EPCS, organizations must meet a number of DEA requirements. These requirements are designed to track and audit the connection between practitioners and the signatures they use for EPCS orders, including provider identity proofing, logical access control, two-factor authentication, and various reporting requirements. It is important to note that traditional token solutions are not sufficient to meet the DEA requirements for EPCS.
Understanding these requirements is essential to ensuring a fully compliant EPCS process. At the same time, it is important to consider the impact to clinical workflow when making key decisions throughout the EPCS initiative.
Join this webinar to learn:
- The benefits of moving to EPCS
- The full DEA requirements
- Common misconceptions about EPCS and how to avoid them
- Considerations when selecting a solution, particularly around two-factor authentication
- Measurable results other organizations have achieved through successful EPCS implementations
Dan Borgasano is the director of product marketing for Imprivata Confirm ID™. He has more than 10 years of experience in healthcare IT security, including expertise in the DEA requirements and best practices for electronic prescribing of controlled substances (EPCS). Dan is a graduate of Syracuse University in Syracuse, N.Y.